Therapy of tic-disorders;Therapie der tic-störungen

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 32, Issue 4, 2004, Pages 245-263

  Roessner, Veit ^a   Banaschewski, Tobias ^a   Rothenberger, Aribert ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Behaviour therapy; Children and adolescents; Drugs; Therapy; Tic disorder

Indexed keywords

CLONIDINE; DOPAMINE RECEPTOR BLOCKING AGENT; GUANFACINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SULPIRIDE; TIAPRIDE; ZIPRASIDONE;

BEHAVIOR DISORDER; BEHAVIOR THERAPY; ELECTROCARDIOGRAPHY; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PSYCHOTHERAPY; REVIEW; TIC;

ANTIPSYCHOTIC AGENTS; BEHAVIOR THERAPY; BENZAMIDES; CHILD; CLONIDINE; COMBINED MODALITY THERAPY; HUMANS; RISPERIDONE; TIC DISORDERS;

EID: 8544283833     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: 10.1024/1422-4917.32.4.245     Document Type: Review

References (137)

1. Allison, D. B. & Casey, D. E. (2001). Antipsychotic-induced weight gain: a review of the literature. The Journal of Clinical Psychiatry 62, Suppl. 7, 22-31.
2. Aman, M. G., Armstrong, S., Buican, B. & Sillick, T. (2002). Four-year follow-up of children with low intelligence and ADHD: a replication. Research in Developmental Disabilities 23, 119-134.
3. Arzneimittelinformationssystem (AMIS) von BfArM (Bundes-institut für Arzneimittel und Medizinprodukte), PEI (Paul-Ehrlich-Institut-Bundesamt für Sera und Impfstoffe), BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit), 2004.
4. Azrin, N. H. & Peterson, A. L. (1988). Habit reversal for the treatment of Tourette syndrome. Behaviour Research and Therapy 26, 347-351.
5. Banaschewski, T. & Rothenberger, A. (1997). Verhaltenstherapie bei Tic-Störungen. In: F. Petermann (Ed.), Kinderverhaltenstherapie. Grundlagen, Anwendungen und manualisierte Triainingsprogramme, (pp. 204-243). Hohengehren: Schneider.
6. Banaschewski, T. & Rothenberger, A. (1998). Diagnostische Leitlinien und verhaltenstherapeutische Verfahren bei Tic-Störungen. Kindheit und Entwicklung 7, 99-111.
7. Banaschewski, T., Woerner, W. & Rothenberger, A. (2003). Pre-monitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. Developmental Medicine and Child Neurology 45, 700-703.
8. Baving, L. & Schmidt, M. H. (2000). [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system]. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 28, 35-44.
9. Baving, L. & Schmidt, M. H. (2001a). [Evaluated treatment approaches in child and adolescent psychiatry 1]. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 29, 189-205.
10. Baving, L. & Schmidt, M. H. (2001b). [Evaluated treatment approaches in child and adolescent psychiatry II]. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 29, 206-220.
11. Bengi Semerci, Z. (2000). Olanzapine in Tourette's disorder. Journal of the American Academy of Child and Adolescent Psychiatry 39, 140.
12. Bergin, A., Waranch, H. R., Brown, J., Carson, K. & Singer, H. S. (1998). Relaxation therapy in Tourette syndrome: a pilot study. Pediatric Neurology 18, 136-142.
13. Bock, N., Quentin, D. J., Hüther, G., Moll, G. H. & Rothenberger, A. (submitted). Very early treatment with fluoxetine and reboxetine causing long lasting changes of the serotonin but not the noradrenaline transporter in the frontal cortex of rats.
14. Bruggeman, R., van der Linden, C., Buitelaar, J. K., Gericke, G. S., Hawkridge, S. M. & Temlett, J. A. (2001). Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. The Journal of Clinical Psychiatry 62, 50-56.
15. Bruun, R. D. (1988). Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder. The American Journal of Psychiatry 145, 621-624.
16. Bruun, R. D. & Budman, C. L. (1996). Risperidone as a treatment for Tourette's syndrome. The Journal of Clinical Psychiatry 57, 29-31.
17. Budman, C. L., Gayer, A., Lesser, M., Shi, Q. & Bruun, R. D. (2001). An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. The Journal of Clinical Psychiatry 62, 290-294.
18. Budman, C. L. & Gayer, A. I. (2001). Low blood glucose and olanzapine. The American Journal of Psychiatry 158, 500-501.
19. Cantwell, D. P., Swanson, J. & Connor, D. F. (1997). Case study: adverse response to clonidine. Journal of the American Academy of Child and Adolescent Psychiatry 36, 539-544.
20. Chouza, C., Romero, S., Lorenzo, J., Camano, J. L., Fontana, A. P., Alterwain, P., Cibils, D., Gaudiano, J., Feres, S. & Solana, J. (1982). [Clinical trial of tiapride in patients with dyskinesia (author's transl)]. La semaine des hopitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 58, 725-733.
21. Clark, M. A., Bray, M. A. & Kehle, T. J. (2001). A school-based intervention designed to reduce the frequency of tics in children with Tourette's syndrome. School Psychology Review 30, 11-22.
22. Culbertson, F. M. (1989). A four-step hypnotherapy model for Gilles de la Tourette's syndrome. The American Journal of Clinical Hypnosis 31, 252-256.
23. Czobor, P., Volavka, J., Sheitman, B., Lindenmayer, J. P., Citrome, L., McEvoy, J., Cooper, T. B., Chakos, M. & Lieberman, J. A. (2002). Antipsychotic-induced weight gain and therapeutic response: a differential association. Journal of Clinical Psychopharmacology 22, 244-251.
24. Dalery, J., Chauvin, C., Maillet, J. & de Villard, R. (1985). Clinical trial of tiapride in children with tic disorders. Journal of Neurology 232, 160.
25. Diantoniis, M. R., Henry, K. M., Partridge, P. A. & Soucar, E. (1996). Tics and rispendone.. Journal of the American Academy of Child and Adolescent Psychiatry 35, 839-840.
26. Dion, Y., Annable, L., Sandor, P. & Chouinard, G. (2002). Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology 22, 31-39.
27. Döpfner, M. (1996). Behandlung eines Jungen mit Tourette-Syndrom durch Reaktionsumkehr (habit reversal) und Verstärkerrückgabe (response cost). Kindheit und Entwicklung 5, 189-196.
28. Döpfner, M. (1999a). Tics. In: H. C. Steinhausen & M. von Aster (Eds.), Verhaltenstherapie und Verhaltensmedizin bei Kindern und Jugendlichen (pp. 161-186). Weinheim: Psychologische Verlags Union.
29. Döpfner, M. (1999b). Zwangsstörungen. In: H. C. Steinhausen & M. von Aster (Eds.), Verhaltenstherapie und Verhaltensmedizin bei Kindern und Jugendlichen (pp. 276-328). Weinheim: PVU.
30. Döpfner, M. (2003). Familien-, kind- und schulzentrierte verhaltenstherapeutische Ansätze. Vortrag, Wissenschaftlicher Kongress der Kinder- und Jugendpsychiatrie und Psychotherapie. Wien.
31. Döpfner, M. & Reister, C. (2000) Tic-Störungen. In: F. Petermann (Ed.), Fallbuch der klinischen Kinderpsychologie und -psychotherapie (pp. 71-96). Göttingen: Hogrefe.
32. Dose, M. & Lange, H. W. (2000). The benzamide tiapride: treatment of extrapyramidal motor and other clinical syndromes. Pharmacopsychiatry 33, 19-27.
33. Drtilkova, I., Balatikova, B., Lemonova, H. & Zank, J. (1996). Therapeutic effects of clonazepam in children with tic syndrome. Homeostasis Health and Disease 37, 216.
34. Eapen, V., Katona, C. L. E., Barnes, T. R. E. & Robertson, M. M. (1993). Sulpiride induced tardive dyskinesia in a person with Gilles de la Tourette syndrome. Journal of Psychopharmacology 7, 290-292.
35. Eggers, C., Olbricht, T. & Rothenberger, A. (1983). Neurobiological findings in children with tics and Gilles de la Tourette syndrome. In: M. Ackenheil & N. Matussek (Eds.), Special aspects of psychopharmacology (pp. 191-202). Paris: Expansion Scientifique Francaise.
36. Eggers, C., Rothenberger, A. & Berghaus, U. (1988a). Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. European Archives of Psychiatry and Neurological Sciences 237, 223-229.
37. Eggers, C., Rothenberger, A. & Berghaus, U. (1988b): Tic-Krankheit. Therapiewoche Pädiatrie 1, 51-57.
38. Eggers, C., Schepker, R. & Oades, R. D. (1993). Exacerbation and provocation of tics by Imipramine and Sulpiride. European Child & Adolescent psychiatry 2, 169-176.
39. Fennig, S., Fennig, S. N., Pato, M. & Weitzman, A. (1994). Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. The British Journal of Psychiatry; the Journal of Mental Science 164, 839-841.
40. Findley, D. B., Leckman, J. F., Katsovich, L., Lin, H., Zhang, H., Grantz, H., Otka, J., Lombroso, P.J. & King, R.A. (2003). Development of the Yale Children's Global Stress Index (YCGSI) and its application in children and adolescents with Tourette's syndrome and obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 42, 450-457.
41. Forner-Valero, J., Aymerich, V. B., Oritz-Lopez, A. (1986). Comperative study of the effects of tiapride and a placebo on the involuntary movements and manual ability of children with cerebromotor disorders. Neuropsychiatrie de l' Enfance et de l'Adolescence 34, 213-216.
42. Freeman, R. D., Fast, D. K., Burd, L., Kerbeshian, J., Robertson, M. M. & Sandor, P. (2000). An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Developmental Medicine and Child Neurology 42, 436-447.
43. Gaffney, G. R., Perry, P. J., Lund, B. C., Bever-Stille, K. A., Arndt, S. & Kuperman, S. (2002). Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 41, 330-336.
44. Giakas, W. J. (1995). Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder. The American Journal of Psychiatry 152, 1097-1098.
45. Gilbert, D. L., Batterson, J. R., Sethuraman, G. & Sallee, F. R. (2004). Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. Journal of the American Academy of Child and Adolescent Psychiatry 43, 206-214.
46. Goetz, C. G. (1992). Clonidine and clonazepam in Tourette syndrome. Advances in Neurology 58, 245-251.
47. Goodman, R., Scott, S. & Rothenberger, A. (2000). Kinderpsychiatrie kompakt. Darmstadt: Steinkopff.
48. Hauser, R. A. & Zesiewicz, T. A. (1995). Sertraline-induced exacerbation of tics in Tourette's syndrome. Movement Disorders 10, 682-684.
49. Hoogduin, K., Verdellen, C. & Cath, D. (1997). Exposure and Response Prevention in the Treatment of Gilles de la Tourette's Syndrome: Four Case Studies. Clinical Psychology and Psychotherapy 4, 125-135.
50. Karam-Hage, M. & Ghaziuddin, N. (2000). Olanzapine in Tourette's disorder. Journal of the American Academy of Child and Adolescent Psychiatry 39, 139.
51. Kessler, A. R. (2001). Clonidine treatment increases tics in patients with Tourette syndrome: case report. Journal of Child Neurology 16, 380-381.
52. Klepel, H., Gebelt, H., Koch, R. D. & Tzenow, H. (1988). [Treatment of extrapyramidal hyperkineses in childhood with tiapride]. Psychiatrie, Neurologie, und medizinische Psychologie 40, 516-522.
53. Kofoed, L., Tadepalli, G., Oesterheld, J. R., Awadallah, S. & Shapiro, R. (1999). Case series: clonidine has no systematic effects on PR or QTc intervals in children. Journal of the American Academy of Child and Adolescent Psychiatry 38, 1193-1196.
54. Krishnamoorthy, J. & King, B. H. (1998). Open-label olanzapine treatment in five preadolescent children. Journal of Child and Adolescent Psychopharmacology 8, 107-113.
55. Kuperman, S. (2003). Tics and Tourette's syndrome in childhood. Seminars in Pediatric Neurology 10, 35-40.
56. Kurlan, R., Behr, J., Medved, L., Shoulson, I., Pauls, D., Kidd, J. R. & Kidd, K. K. (1986). Familial Tourette's syndrome: report of a large pedigree and potential for linkage analysis. Neurology 36, 772-776.
57. Kwak, C. H., Hanna, P. A. & Jankovic, J. (2000). Botulinum toxin in the treatment of tics. Archives of Neurology 57, 1190-1193.
58. Lang, A. E. (2001). Update on the treatment of tics. Advances in Neurology 85, 355-362.
59. Leckman, J. F. (2002). Tourette's syndrome. Lancet 360, 1577-1586.
60. Leckman, J. F., Hardin, M. T., Riddle, M. A., Stevenson, J., Ort, S. I. & Cohen, D. J. (1991). Clonidine treatment of Gilles de la Tourette's syndrome. Archives of General Psychiatry 48, 324-328.
61. Leckman, J. F., Ort, S., Caruso, K. A., Anderson, G. M., Riddle, M. A. & Cohen, D. J. (1986). Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects. Archives of General Psychiatry 43, 1168-1176.
62. Leonard, H. L. & Swedo, S. E. (2001). Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). The international Journal of Neuropsychopharmacology 4, 191-198.
63. Levy, F. (1998). Clonidine: adverse responses. Journal of Paediatrics and Child Health 34, 501-502.
64. Lichter, D. G. & Jackson, L. A. (1996). Predictors of clonidine response in Tourette syndrome: implications and inferences. Journal of Child Neurology 11, 93-97.
65. Linet, L. S. (1985). Tourette syndrome, pimozide, and school phobia: the neuroleptic separation anxiety syndrome. The American Journal of Psychiatry 142, 613-615.
66. Loiselle, C. R., Lee, O., Moran, T. H. & Singer, H. S. (2004). Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Movement Disorders 19, 390-396.
67. Lombroso, P. J., Scahill, L., King, R. A., Lynch, K. A., Chappell, P. B., Peterson, B. S., McDougle, C. J. & Leckman, J. F. (1995). Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. Journal of the American Academy of Child and Adolescent Psychiatry 34, 1147-1152.
68. Margolese, H. C., Annable, L. & Dion, Y. (2002). Depression and dysphoria in adult and adolescent patients with Tourette's disorder treated with risperidone. The Journal of Clinical Psychiatry 63, 1040-1044.
69. Mathe, J. F., Cler, J. M. & Venisse, J. L. (1978). [Therapeutic use of tiapride in movement disorders]. La semaine des hôpitaux: organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 54, 517-520.
70. McCracken, J. T., Sallee, F. R. & Leonard, H. L. (2003). Improvement of ADDHD by Atomoxetine in Children with Tic Disorders (Poster). Edited by AACAP. Miami.
71. McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S. & Price, L. H. (2000). A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry 57, 794-801.
72. Meyer, J. M. (2001). Novel antipsychotics and severe hyperlipidemia. Journal of Clinical Psychopharmacology 21, 369-374.
73. Meyer, J. M. (2002). A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated in patients: metabolic outcomes after 1 year. The Journal of Clinical Psychiatry 63, 425-433.
74. Miguel, E. C., Shavitt, R. G., Ferrao, Y. A., Brotto, S. A. & Diniz, J. B. (2003). How to treat OCD in patients with Tourette syndrome. Journal of Psychosomatic Research 55, 49-57.
75. Mikkelsen, E. J., Detlor, J. & Cohen, D. J. (1981). School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder. The American Journal of Psychiatry 138, 1572-1576.
76. Miltenberger, R. G. & Fuqua, R. W. (1985a). A comparison of contingent vs non-contingent competing response practice in the treatment of nervous habits. Journal of Behavior Therapy and Experimental Psychiatry 16, 195-200.
77. Miltenberger, R. G., Fuqua, R. W. & McKinley, T. (1985b). Habit reversal with muscle tics: replication and component analysis. Behavior Therapy 16, 39-50.
78. Moll, G. H., Eysenbach, K., Woerner, W., Banaschewski, T., Schmidt, M. H. & Rothenberger, A. (2000). Quantitative and qualitative aspects of obsessive-compulsive behaviour in children with attention-deficit hyperactivity disorder compared with tic disorder. Acta Psychiatrica Scandinavica 101, 389-394.
79. Mukaddes, N. M. & Abali, O. (2003). Quetiapine treatment of children and adolescents with Tourette's disorder. Journal of Child and Adolescent Psychopharmacology 13, 295-299.
80. Muller, N., Putz, A., Klages, U., Hofschuster, E., Straube, A. & Ackenheil, M. (1994). Blunted growth hormone response to clonidine in Gilles de la Tourette syndrome. Psychoneuroendocrinology 19, 335-341.
81. Muller-Vahl, K. R., Schneider, U., Prevedel, H., Theloe, K., Kolbe, H., Daldrup, T. & Emrich, H. M. (2003). Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. The Journal of Clinical Psychiatry 64, 459-465.
82. O'Connor, K., Gareau, D. & Borgeat, F. (1995). Muscle control in chronic tic disorders. Biofeedback Self Regulationl 20, 111-122.
83. O'Connor, K., Gareau, D. & Borgeat, F. (1997). A Comparison of a Behavioural and a Cognitive-Behavioural Approach to the Management of Chronic Tic Disorders. Clinical Psychology and Psychotherapy 4, 75-144.
84. O'Connor, K. P., Brault, M., Robillard, S., Loiselle, J., Borgeat, F. & Stip, E. (2001). Evaluation of a cognitive-behavioural program for the management of chronic tic and habit disorders. Behaviour Research and Therapy 39, 667-681.
85. Onofrj, M., Paci, C., D'Andreamatteo, G. & Toma, L. (2000), Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. Journal of Neurology 247, 443-446.
86. Pasquier, C. & Pouplard, F. (1977). [Reflections on child tics. Apropos of a therapeutic trial]. Rev. Neuropsychiatr. Infant 25, 645-651.
87. Perlmutter, S. J., Leitman, S. F., Garvey, M. A., Hamburger, S., Feldman, E., Leonard, H. L. & Swedo, S. E. (1999). Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354, 1153-1158.
88. Peterson, A. L. & Azrin, N. H. (1992). An evaluation of behavioural treatments for Tourette syndrome. Behaviour Research and Therapy 30, 167-174.
89. Peterson, A. L. & Azrin, N. H. (1993). Behavioral and pharmacological treatment for Tourette's syndrome: a review. Applied and Preventive Psychology 2.
90. Peterson, A. L., Campise, R. L., Azrin, N. H. (1994). Behavioral and pharmacological treatments for tic and habit disorders: a review. Journal of Developmental and Behavioral Pediatrics 15, 430-441.
91. Peterson, B. S. (1996). Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. The Journal of Clinical Psychiatry 57, 24-34.
92. Piacentini, J. & Chang, S. (2001). Behavioral treatments for Tourette syndrome and tic disorders: state of the art. Advances in Neurology 85, 319-331.
93. Regeur, L., Pakkenberg, B., Fog, R. & Pakkenberg, H. (1986). Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome. Journal of Neurology Neurosurg Psychiatry 49, 791-795.
94. Riederer, F., Stamenkovic, M., Schindler, S. D. & Kasper, S. (2002). [Tourette's syndrome - a review]. Nervenarzt 73, 805-819.
95. Robertson, M. M., Scull, D. A., Eapen, V. & Trimble, M. R. (1996). Risperidone in the treatment of Tourette syndrome: a retrospective case note study. Journal of Psychopharmacology 10, 317-320.
96. Robertson, M. M. & Stern, J. S. (2000). Gilles de la Tourette syndrome: symptomatic treatment based on evidence. European Child & Adolescent Psychiatry 9, Suppl. I, 160-75.
97. Ross, M. S. & Moldofsky, H. (1978). A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. The American Journal of Psychiatry 135, 585-587.
98. Rothenberger, A. (1984). Therapie der Tic-Störungen. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 12, 284-301.
99. Rothenberger, A. (1991). Wenn Kinder Tics entwickeln. Stuttgart: Fischer.
100. Rothenberger, A. & Banaschewski, T. (2003). Ticstörungen (F.95). Arbeitsgemeinschaft Medizinischer Fachgesellschaften (AWMF, Ed.), Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter (pp. 311-317). Köln: Deutscher Ärzte Verlag.
101. Rothenberger, A. & Banaschewski, T. (in press). Tic-Disorders. In: C. Grillberg, R. Harrington & H. C. Steinhausen (Eds.), A clinician's handbook of child and adolescent psychiatry. Cambridge: Cambridge University Press.
102. Rothenberger, A., Banaschewski, T. & Siniatchkin, M. (2003). Tic-Störungen. In: B. Herpetz-Dahlmann, F. Resch, M. Schulte-Markwort & A. Warnke (Eds.), Entwicklungspsychiatrie (pp. 548-569). Stuttgart: Schattauer-Verlag.
103. Rothenberger, A. & Eggers, C. (1982). The influence of tiapride on the ERPs of children with multiple tics. In: A. Rothenberger (Ed.), Event-related potentials in children (pp. 423-428). Amsterdam: Elsevier.
104. Rothenberger, A., Gorskowski, I. & Woerner, W. (2001). Fragebogen zum Tourette-Syndrom: Bisherige Ergebnisse, kritische Betrachtung und Weiterentwicklung (zur Lage des Tourette-Syndroms in Deutschland). Bericht für die Tourette-Gesellschaft e.V.
105. Ruth, U., Mayer-Rosa, J., Schlamp, D. & Freisleder, F. J. (2000). [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine]. Zeitschrift für Kinderlind Jugendpsychiatrie und Psychotherapie 28, 105-108.
106. Sallee, F. R., Gilbert, D. L., Vinks, A. A., Miceli, J. J., Robarge, L. & Wilner, K. (2003). Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission. Journal of the American Academy of Child and Adolescent Psychiatry 42, 902-907.
107. Sallee, F. R., Kurlan, R., Goetz, C. G., Singer, H., Scahill, L., Law, G., Dittman, V. M. & Chappell, P. B. (2000). Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. Journal of the American Academy of Child and Adolescent Psychiatry 39, 292-299.
108. Sallee, F. R., Nesbitt, L., Jackson, C., Sine, L. & Sethuraman, G. (1997). Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. The American Journal of Psychiatry 154, 1057-1062.
109. Sandor, P. (2003). Pharmacological management of tics in patients with TS. Journal of Psychosomatic Research 55, 41-48.
110. Sandor, P., Musisi, S., Moldofsky, H. & Lang, A. (1990). Tourette syndrome: a follow-up study. Journal of Clinical Psychopharmacology 10, 197-199.
111. Scahill, L., Chappell, P. B., King, R. A. & Leckman, J. F. (2000). Pharmacologic treatment of tic disorders. Child and Adolescent Psychiatric Clinics of North America 9, 99-117.
112. Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L. & Peterson, B. S. (2003). A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60, 1130-1135.
113. Scatton, B., Cohen, C., Perrault, G., Oblin, A., Claustre, Y., Schoemaker, H., Sanger, D. J., Rouquier, L. & Porsolt, R. (2001). The preclinical pharmacologic profile of tiapride. European Psychiatry 16, Suppl. 1, 29-34.
114. Schenk, G. K., Dux, R., Filler, W., Olbrich, H., Pompe, E. & Zerbin, D. (1982). ERP and drugs - proposal for a multi-variante approach in studying drug effects by utilizing single ERP features. In: A. Rothenberger (Ed.), Event-related potentials in children (pp. 417-428). Amsterdam: Elsevier.
115. Scholz, A. & Rothenberger, A. (2001). Mein Kind hat Tics und Zwänge. Göttingen: Vandenhoeck & Ruprecht.
116. Shapiro, E., Shapiro, A. K., Fulop, G., Hubbard, M., Mandeli, J., Nordlie, J. & Phillips, R. A. (1989). Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Archives of General Psychiatry 46, 722-730.
117. Shapiro, E. & Shapiro, E. (1998) Treatment of tic disorders with haloperidol. In-. D. J. Cohen, R. D. Bruun & J. F. Leckman (Eds.), Tourette syndrome and tic disorders (pp. 267-280). New York: John Wiley and Sons.
118. Shulman, L. M., Singer, C. & Weiner, W. J. (1995). Risperidone in Gilles de la Tourette syndrome. Neurology 45, 1419.
119. Silva, R. R., Magee, H. J. & Friedhoff, A. J. (1993). Persistent tardive dyskinesia and other neuroleptic-related dyskinesias in Tourette's disorder. Journal of Child and Adolescent Psychopharmacology 3, 137-144.
120. Silva, R. R., Munoz, D. M., Barickman, J. & Friedhoff, A. J. (1995). Environmental factors and related fluctuation of symptoms in children and adolescents with Tourette's disorder. Journal of Child Psychology and Psychiatry and allied Disciplines 36, 305-312.
121. Silver, A. A., Shytle, R. D., Philipp, M. K., Wilkinson, B. J., McConville, B. & Sanberg, P. R. (2001). Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study. The Journal of Clinical Psychiatry 62, 707-714.
122. Singer, H. S. & Walkup, J. T. (1991). Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment. Medicine (Baltimore) 70, 15-32.
123. Stamenkovic, M., Aschauer, H. & Kasper, S. (1994). Risperidone for Tourette's syndrome. Lancet 344, 1577-1578.
124. Stamenkovic, M., Schindler, S. D., Aschauer, H. N., De Zwaan, M., Willinger, U., Resinger, E. & Kasper, S. (2000). Effective open-label treatment of tourette's disorder with olanzapine. International Clinical Psychopharmacology 15, 23-28.
125. Steingard, R., Biederman, J., Spencer, T., Wilens, T. & Gonzalez, A. (1993). Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry 32, 350-353.
126. Sukhodolsky, D. G., Scahill, L., Zhang, H., Peterson, B. S., King, R. A., Lombroso, P. J., Katsovich, L., Findley, D. & Leckman, J. F. (2003). Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment. Journal of the American Academy of Child and Adolescent Psychiatry 42, 98-105.
127. Tansey, M. A. (1986). A simple and a complex tic (Gilles de la Tourette's syndrome): their response to EEG sensorimotor rhythm biofeedback training. International Journal of Psychophysiology 4, 91-97.
128. Temel, Y. & Visser-Vandewalle, V. (2004). Surgery in Tourette syndrome. Movement Disorders 19, 3-14.
129. Tourette's-Syndrome-Study-Group (2002). Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 58, 527-536.
130. Tourette syndrome International database Consortium (1998). http://www.cw.bc.ca/mentalhealth/tic/.
131. Trillet, M., Moreau, T., Dalery, J., de Villard, R. & Aimard, G. (1990). [Treatment of Gilles de la Tourette's disease with amisulpride]. La Presse médicale 19, 175.
132. van der Linden, C., Bruggeman, R. & van Woerkom, T. C. (1994). Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone. Movement Disorders 9, 687-688.
133. Verdellen, C. W., Keijsers, G. P., Cath, D. C. & Hoogduin, C. A. (2004). Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study. Behaviour Research and Therapy 42, 501-511.
134. Weiden, P. & Brunn, R. (1987). Worsening of Tourette's disorder due to neuroleptic-induced akathisia. The American Journal of Psychiatry 144, 504-505.
135. Welch, R. & Chue, P. (2000). Antipsychotic agents and QT changes. Journal of Psychiatry & Neuroscience 25, 154-160.
136. Wilhelm, S., Deckersbach, T., Coffey, B. J., Bohne, A., Peterson, A. L. & Baer, L. (2003). Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. The American Journal of Psychiatry 160, 1175-1177.
137. Wolf, D. V. & Wagner, K. D. (1993). Tardive dyskinesia, tardive dystonia, and tardive Tourette's syndrome in children and adolescents. Journal of Child and Adolescent Psychopharmacology 3, 175-198.